Mild cognitive impairment in Parkinson disease: Heterogenous mechanisms

Journal of Neural Transmission

Volumn 120, Issue 1, 2013, Pages 157-167

  Jellinger, Kurt A ^a  

^a INSTITUTE OF CLINICAL NEUROBIOLOGY   (Austria)

Author keywords

Biomarkers; Dementia; Diagnostic consensus criteria; Heterogenous mechanisms in PD MCI; Mild cognitive impairment; Neuropathology; Parkinson disease

Indexed keywords

ARTICLE; DSM-IV; HUMAN; LEWY BODY; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

HUMANS; MILD COGNITIVE IMPAIRMENT; PARKINSON DISEASE;

EID: 84872357917     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-012-0771-5     Document Type: Article

References (143)

1. Aarsland D, Bronnick K, Larsen JP, Tysnes OB, Alves G (2009) Cognitive impairment in incident, untreated Parkinson disease: the norwegian parkwest study. Neurology 72:1121-1126
2. Aarsland D, Bronnick K, Williams-Gray C, Weintraub D, Marder K, Kulisevsky J, Burn D, Barone P, Pagonabarraga J, Allcock L, Santangelo G, Foltynie T, Janvin C, Larsen JP, Barker RA, Emre M (2010) Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology 75:1062-1069
3. Aarsland D, Bronnick K, Fladby T (2011) Mild cognitive impairment in Parkinson's disease. Curr Neurol Neurosci Rep 11:371-378
4. Adler CH, Beach TG (2010) Variability of diffuse plaques and amyloid angiopathy in Parkinson's disease with mild cognitive impairment. Acta Neuropathol 120:831-832
5. Adler CH, Caviness JN, Sabbagh MN, Shill HA, Connor DJ, Sue L, Evidente VG, Driver-Dunckley E, Beach TG (2010) Heterogeneous neuropathological findings in Parkinson's disease with mild cognitive impairment. Acta Neuropathol 120:827-828
6. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH (2011) The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7:270-279
7. Alves G, Bronnick K, Aarsland D, Blennow K, Zetterberg H, Ballard C, Kurz MW, Andreasson U, Tysnes OB, Larsen JP, Mulugeta E (2010) CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the norwegian parkwest study. J Neurol Neurosurg Psychiatry 81:1080-1086
8. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington
9. Ash EL, Korczyn AD (2011) Is amnestic mild cognitive impairment a useful concept? Aging Health 7:107-122
10. Barone P, Aarsland D, Burn D, Emre M, Kulisevsky J, Weintraub D (2011) Cognitive impairment in nondemented Parkinson's disease. Mov Disord 26:2483-2495
11. Barrio JR, Kepe V, Satyamurthy N, Huang SC, Small G (2008) Amyloid and tau imaging, neuronal losses and function in mild cognitive impairment. J Nutr Health Aging 12:61S-65S (Pubitemid 351156017)
12. Beach TG, Adler CH, Lue LF, Sue L, Bachalakuri J, Henry-Watson J, Sasse J, Boyer S, Shirohi S, Brooks R, Eschbacher J, White CL 3rd, Akiyama H, Caviness J, Shill HA, Connor DJ, Sabbagh MN, Walker DG, Arizona Parkinson's Disease Consortium (2009) Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta Neuropathol 117:613-634
13. Bennett DA, Schneider JA, Bienias JL, Evans DA, Wilson RS (2005) Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology 64:834-841 (Pubitemid 40316322)
14. Beyer MK, Janvin CC, Larsen JP, Aarsland D (2007) A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry. J Neurol Neurosurg Psychiatry 78:254-259 (Pubitemid 46579662)
15. Bohnen NI, Kaufer DI, Hendrickson R, Ivanco LS, Lopresti BJ, Constantine GM, Mathis ChA, Davis JG, Moore RY, Dekosky ST (2006) Cognitive correlates of cortical cholinergic denervation in Parkinson's disease and parkinsonian dementia. J Neurol 253:242-247 (Pubitemid 43255898)
16. Bohnen NI, Koeppe RA, Minoshima S, Giordani B, Albin RL, Frey KA, Kuhl DE (2011) Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study. J Nucl Med 52:848-855
17. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24:197-211 (Pubitemid 36007810)
18. Britt WG III, Hansen AM, Bhaskerrao S, Larsen JP, Petersen F, Dickson A, Dickson C, Kirsch WM (2011) Mild cognitive impairment: prodromal Alzheimer's disease or something else? J Alzheimers Dis 27:543-551
19. Bronnick K, Ehrt U, Emre M, De Deyn PP, Wesnes K, Tekin S, Aarsland D (2006) Attentional deficits affect activities of daily living in dementia-associated with Parkinson's disease. J Neurol Neurosurg Psychiatry 77:1136-1142 (Pubitemid 44453247)
20. Brys M, Pirraglia E, Rich K, Rolstad S, Mosconi L, Switalski R, Glodzik-Sobanska L, De Santi S, Zinkowski R, Mehta P, Pratico D, Saint Louis LA, Wallin A, Blennow K, de Leon MJ (2009) Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment. Neurobiol Aging 30:682-690
21. Caviness JN, Driver-Dunckley E, Connor DJ, Sabbagh MN, Hentz JG, Noble B, Evidente VG, Shill HA, Adler CH (2007) Defining mild cognitive impairment in Parkinson's disease. Mov Disord 22:1272-1277 (Pubitemid 47325034)
22. Coen RF (2011) Neuropsychological assessment of mild cognitive impairment/prodromal Alzheimer's disease. Aging Health 7:155-162
23. Compta Y, Parkkinen L, O'Sullivan SS, Vandrovcova J, Holton JL, Collins C, Lashley T, Kallis C, Williams DR, de Silva R, Lees AJ, Revesz T (2011) Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important? Brain 134:1493-1505
24. Costello A, Al Khamees H, Moriarty J, Hulse N, Malik I, Selway R, Clough C, Ashkan K, Michael S (2011) Non-amnestic mild cognitive impairment is a prominent aspect in Parkinson's disease patients being considered for deep brain stimulation. Basal Ganglia 1:213-220
25. Dalrymple-Alford JC, Livingston L, MacAskill MR, Graham C, Melzer TR, Porter RJ, Watts R, Anderson TJ (2011) Characterizing mild cognitive impairment in Parkinson's disease. Mov Disord 26:629-636
26. Defrancesco M, Marksteiner J, Deisenhammer EA, Hinterhuber H, Weiss EM (2009) Association of mild cognitive impairment (MCI) and depression. Neuropsychiatr 23:144-150
27. Farlow MR, Cummings J (2008) A modern hypothesis: The distinct pathologies of dementia associated with Parkinson's disease versus Alzheimer's disease. Dement Geriatr Cogn Disord 25:301-308 (Pubitemid 351562950)
28. Frank G, Hennig-Fast K, Klunemann HH, Schmitz G, Greenlee MW (2011) Differential impact of ApoE epsilon4 on cortical activation during famous face recognition in cognitively intact individuals and patients with amnestic mild cognitive impairment. Alzheimer Dis Assoc Disord 25:250-261
29. Ganguli M, Dodge HH, Shen C, DeKosky ST (2004) Mild cognitive impairment, amnestic type: an epidemiologic study. Neurology 63:115-121 (Pubitemid 38943788)
30. Ganguli M, Snitz BE, Saxton JA, Chang CC, Lee CW, Vander Bilt J, Hughes TF, Loewenstein DA, Unverzagt FW, Petersen RC (2011) Outcomes of mild cognitive impairment by definition: a population study. Arch Neurol 68:761-767
31. Gauthier S, Touchon J (2005) Mild cognitive impairment is not a clinical entity and should not be treated. Arch Neurol 62:1164-1166 Discussion 1167 (Pubitemid 41043745)
32. Gauthier S, Reisberg B, Zaudig M, Petersen RC, Ritchie K, Broich K, Belleville S, Brodaty H, Bennett D, Chertkow H, Cummings JL, de Leon M, Feldman H, Ganguli M, Hampel H, Scheltens P, Tierney MC, Whitehouse P, Winblad B (2006) Mild cognitive impairment. Lancet 367:1262-1270
33. Goldman JG, Litvan I (2011) Mild cognitive impairment in Parkinson's disease. Minerva Med 102:441-459
34. Goldman JG, Stebbins GT, Bernard B, Goetz CG (2011) Clinical Differences among PD-MCI Subtypes (abs). Ann Neurol 70(suppl 15):S16
35. Guillozet AL, Weintraub S, Mash DC, Mesulam MM (2003) Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. Arch Neurol 60:729-736 (Pubitemid 36569891)
36. Haense C, Kalbe E, Herholz K, Hohmann C, Neumaier B, Krais R, Heiss WD (2010) Cholinergic system function and cognition in mild cognitive impairment. Neurobiol Aging, (in press). http://dx.doi.org/10.1016/j.neurobiolaging.2010.08. 015
37. Haldenwanger A, Eling P, Kastrup A, Hildebrandt H (2010) Correlation between cognitive impairment and CSF biomarkers in amnesic MCI, non-amnesic MCI, and Alzheimer's disease. J Alzheimers Dis 22:971-980
38. Han JW, Lee SB, Kim TH, Park JH, Lee JJ, Huh YS, Choi EA, Choe JY, Do YJ, Lee DY, Kim KW (2011) Functional impairment in the diagnosis of mild cognitive impairment. Alzheimer Dis Assoc Disord 25:225-229
39. Hanfelt JJ, Wuu J, Sollinger AB, Greenaway MC, Lah JJ, Levey AI, Goldstein FC (2011) An exploration of subgroups of mild cognitive impairment based on cognitive, neuropsychiatric and functional features: analysis of data from the national Alzheimer's coordinating center. Am J Geriatr Psychiatry 19:940-950
40. Hansson O, Zetterberg H, Vanmechelen E, Vanderstichele H, Andreasson U, Londos E, Wallin A, Minthon L, Blennow K (2010) Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment. Neurobiol Aging 31:357-367
41. Haroutunian V, Hoffman LB, Beeri MS (2009) Is there a neuropathology difference between mild cognitive impairment and dementia? Dialogues Clin Neurosci 11:171-179
42. Heister D, Brewer JB, Magda S, Blennow K, McEvoy LK (2011) Predicting MCI outcome with clinically available MRI and CSF biomarkers. Neurology 77:1619-1628
43. Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG (2008) The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord 23:837-844
44. Hilker R, Thomas AV, Klein JC, Weisenbach S, Kalbe E, Burghaus L, Jacobs AH, Herholz K, Heiss WD (2005) Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways. Neurology 65:1716-1722
45. Hirsch E (2008) Is the cholinergic system involved in cognitive impairment in Parkinson's disease? (abs.). In: 6th International Congress on Mental Dysfunctions and Other Non-Motor Features in Parkinson's Disease and Related Disorders, Dresden, Oct 16-19, 2008. Kenes International Geneva, pp Abstract on CD-ROM
46. Huang C, Mattis P, Perrine K, Brown N, Dhawan V, Eidelberg D (2008) Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease. Neurology 70:1470-1477 (Pubitemid 351521942)
47. Israeli-Korn SD, Massarwa M, Schechtman E, Strugatsky R, Avni S, Farrer LA, Friedland RP, Inzelberg R (2010) Mild cognitive impairment is associated with mild parkinsonian signs in a door-to-door study. J Alzheimers Dis 22:1005-1013
48. Jack CR Jr, Lowe VJ, Weigand SD, Wiste HJ, Senjem ML, Knopman DS, Shiung MM, Gunter JL, Boeve BF, Kemp BJ, Weiner M, Petersen RC (2009) Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain 132:1355-1365
49. Jack CR Jr, Wiste HJ, Vemuri P, Weigand SD, Senjem ML, Zeng G, Bernstein MA, Gunter JL, Pankratz VS, Aisen PS, Weiner MW, Petersen RC, Shaw LM, Trojanowski JQ, Knopman DS (2010) Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease. Brain 133:3336-3348
50. Janvin CC, Larsen JP, Aarsland D, Hugdahl K (2006) Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia. Mov Disord 21:1343-1349 (Pubitemid 44613283)
51. Jauhiainen AM, Kangasmaa T, Rusanen M, Niskanen E, Tervo S, Kivipelto M, Vanninen RL, Kuikka JT, Soininen H (2008) Differential hypometabolism patterns according to mild cognitive impairment subtypes. Dement Geriatr Cogn Disord 26:490-498
52. Jellinger KA (2009) Editorial: The neurological substrate of Parkinson disease dementia. J Mov Disord 23:1-3
53. Jellinger KA (2010a) Prevalence and impact of cerebrovascular lesions in Alzheimer and Lewy body diseases. Neurodegener Dis 7:112-115
54. Jellinger KA (2010b) Neuropathology in Parkinson's disease with mild cognitive impairment. Acta Neuropathol 120:829-830 author reply 831
55. Jellinger KA (2010c) The neuropathologic substrate of Parkinson disease dementia. Acta Neuropathol 119:151-153
56. Jellinger KA, Attems J (2008) Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease. Acta Neuropathol 115:427-436
57. Jellinger KA, Seppi K, Wenning GK, Poewe W (2002) Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease. J Neural Transm 109:329-339 (Pubitemid 34251637)
58. Jicha GA, Parisi JE, Dickson DW, Johnson K, Cha R, Ivnik RJ, Tangalos EG, Boeve BF, Knopman DS, Braak H, Petersen RC (2006) Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia. Arch Neurol 63:674-681
59. Jicha GA, Abner E, Schmitt FA, Cooper GE, Stiles N, Hamon R, Carr S, Smith CD, Markesbery WR (2008) Clinical features of mild cognitive impairment differ in the research and tertiary clinic settings. Dement Geriatr Cogn Disord 26:187-192
60. Jicha GA, Abner EL, Schmitt FA, Kryscio RJ, Riley KP, Cooper GE, Stiles N, Mendiondo MS, Smith CD, Van Eldik LJ, Nelson PT (2011) Preclinical AD workgroup staging: pathological correlates and potential challenges. Neurobiol Aging 33(3):622.e1-622.e16
61. Kalaitzakis ME, Pearce RK (2009) The morbid anatomy of dementia in Parkinson's disease. Acta Neuropathol 118:587-598
62. Kehagia AA, Barker RA, Robbins TW (2010) Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease. Lancet Neurol 9:1200-1213
63. Klepac N, Trkulja V, Relja M, Babic T (2008) Is quality of life in non-demented Parkinson's disease patients related to cognitive performance? A clinic-based cross-sectional study. Eur J Neurol 15:128-133
64. Landau SM, Harvey D, Madison CM, Reiman EM, Foster NL, Aisen PS, Petersen RC, Shaw LM, Trojanowski JQ, Jack CR Jr, Weiner MW, Jagust WJ (2010) Comparing predictors of conversion and decline in mild cognitive impairment. Neurology 75:230-238
65. Lee JE, Park HJ, Song SK, Sohn YH, Lee JD, Lee PH (2010) Neuroanatomic basis of amnestic MCI differs in patients with and without Parkinson disease. Neurology 75:2009-2016
66. Liepelt-Scarfone I, Graeber S, Feseker A, Baysal G, Godau J, Gaenslen A, Maetzler W, Berg D (2011) Influence of different cut-off values on the diagnosis of mild cognitive impairment in Parkinson's disease. Parkinsons Dis 2011:540843
67. Litvan I, Aarsland D, Adler CH, Goldman JG, Kulisevsky J, Mollenhauer B, Rodriguez-Oroz MC, Troster AI, Weintraub D (2011) MDS task force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI. Mov Disord 10:1814-1824
68. Luck T, Luppa M, Briel S, Riedel-Heller SG (2010) Incidence of mild cognitive impairment: a systematic review. Dement Geriatr Cogn Disord 29:164-175
69. Lyoo CH, Jeong Y, Ryu YH, Rinne JO, Lee MS (2010) Cerebral glucose metabolism of Parkinson's disease patients with mild cognitive impairment. Eur Neurol 64:65-73
70. Marder K (2010) Cognitive impairment and dementia in Parkinson's disease. Mov Disord 25(Suppl 1):S110-S116
71. Markesbery WR (2010) Neuropathologic alterations in mild cognitive impairment: a review. J Alzheimers Dis 19:221-228
72. Markesbery WR, Schmitt FA, Kryscio RJ, Davis DG, Smith CD, Wekstein DR (2006) Neuropathologic substrate of mild cognitive impairment. Arch Neurol 63:38-46 (Pubitemid 43063860)
73. Martin SB, Smith CD, Collins HR, Schmitt FA, Gold BT (2010) Evidence that volume of anterior medial temporal lobe is reduced in seniors destined for mild cognitive impairment. Neurobiol Aging 31:1099-1106
74. Martinez-Horta S, Kulisevsky J (2011) Is all cognitive impairment in Parkinson's disease "mild cognitive impairment"? J Neural Transm 118:1185-1190
75. McDade EM, Petersen RC (2012) Mild cognitive impairment: Epidemiology, pathology, and clinical assessment. In: DeKosky ST (ed) Dementia. http://www.uptodate.com/contents/mild-cognitive-impairment-epidemiology- pathology-and-clinical-assessment. Accessed 5 Jan 2012
76. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65:1863-1872 (Pubitemid 43970103)
77. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34:939-944 (Pubitemid 14076461)
78. Mitchell AJ, Shiri-Feshki M (2008) Temporal trends in the long term risk of progression of mild cognitive impairment: a pooled analysis. J Neurol Neurosurg Psychiatry 79:1386-1391
79. Molano J, Boeve B, Ferman T, Smith G, Parisi J, Dickson D, Knopman D, Graff-Radford N, Geda Y, Lucas J, Kantarci K, Shiung M, Jack C, Silber M, Pankratz VS, Petersen R (2010) Mild cognitive impairment associated with limbic and neocortical Lewy body disease: a clinicopathological study. Brain 133:540-556
80. Montine TJ, Shi M, Quinn JF, Peskind ER, Craft S, Ginghina C, Chung KA, Kim H, Galasko DR, Jankovic J, Zabetian CP, Leverenz JB, Zhang J (2010) CSF Abeta(42) and tau in Parkinson's disease with cognitive impairment. Mov Disord 25:2682-2685
81. Morris JC, Fulling K (1988) Early Alzheimer's disease: diagnostic considerations. Arch Neurol 45:345-349 (Pubitemid 18081703)
82. Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH, Berg L (2001) Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 58:397-405 (Pubitemid 32217456)
83. Morris JC, Weintraub S, Chui HC, Cummings J, Decarli C, Ferris S, Foster NL, Galasko D, Graff-Radford N, Peskind ER, Beekly D, Ramos EM, Kukull WA (2006) The uniform data set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers. Alzheimer Dis Assoc Disord 20:210-216 (Pubitemid 44900933)
84. Mufson EJ, Binder L, Counts SE, DeKosky ST, deTolledo-Morrell L, Ginsberg SD, Ikonomovic MD, Perez SE, Scheff SW (2011) Mild cognitive impairment: pathology and mechanisms. Acta Neuropathol 123:31-37
85. Muslimovic D, Post B, Speelman JD, Schmand B (2005) Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 65:1239-1245 (Pubitemid 41508217)
86. Nobili F, Abbruzzese G, Morbelli S, Marchese R, Girtler N, Dessi B, Brugnolo A, Canepa C, Drosos GC, Sambuceti G, Rodriguez G (2009a) Amnestic mild cognitive impairment in Parkinson's disease: a brain perfusion SPECT study. Mov Disord 24:414-421
87. Nobili F, De Carli F, Frisoni GB, Portet F, Verhey F, Rodriguez G, Caroli A, Touchon J, Morbelli S, Guerra UP, Dessi B, Brugnolo A, Visser PJ (2009b) SPECT predictors of cognitive decline and Alzheimer's disease in mild cognitive impairment. J Alzheimers Dis 17:761-772
88. O'Dwyer L, Lamberton F, Bokde AL, Ewers M, Faluyi YO, Tanner C, Mazoyer B, O'Neill D, Bartley M, Collins DR, Coughlan T, Prvulovic D, Hampel H (2011) Using diffusion tensor imaging and mixed-effects models to investigate primary and secondary white matter degeneration in Alzheimer's disease and mild cognitive impairment. J Alzheimers Dis 26:667-682
89. Oishi K, Akhter K, Mielke M, Ceritoglu C, Zhang J, Jiang H, Li X, Younes L, Miller MI, van Zijl PC, Albert M, Lyketsos CG, Mori S (2011) Multi-modal MRI analysis with disease-specific spatial filtering: initial testing to predict mild cognitive impairment patients who convert to Alzheimer's disease. Front Neurol 2:54
90. Okonkwo OC, Mielke MM, Griffith HR, Moghekar AR, O'Brien RJ, Shaw LM, Trojanowski JQ, Albert MS (2011) Cerebrospinal fluid profiles and prospective course and outcome in patients with amnestic mild cognitive impairment. Arch Neurol 68:113-119
91. Pa J, Boxer A, Chao LL, Gazzaley A, Freeman K, Kramer J, Miller BL, Weiner MW, Neuhaus J, Johnson JK (2009) Clinical-neuroimaging characteristics of dysexecutive mild cognitive impairment. Ann Neurol 65:414-423
92. Palmer K, Backman L, Winblad B, Fratiglioni L (2008) Mild cognitive impairment in the general population: occurrence and progression to Alzheimer disease. Am J Geriatr Psychiatry 16:603-611
93. Panza F, Frisardi V, Capurso C, D'Introno A, Colacicco AM, Imbimbo BP, Santamato A, Vendemiale G, Seripa D, Pilotto A, Capurso A, Solfrizzi V (2010) Late-life depression, mild cognitive impairment, and dementia: possible continuum? Am J Geriatr Psychiatry 18:98-116
94. Pappata S, Santangelo G, Aarsland D, Vicidomini C, Longo K, Bronnick K, Amboni M, Erro R, Vitale C, Caprio MG, Pellecchia MT, Brunetti A, De Michele G, Salvatore M, Barone P (2011) Mild cognitive impairment in drug-naive patients with PD is associated with cerebral hypometabolism. Neurology 77:1357-1362
95. Pasotti C, Minafra B, Zangaglia R, Sinforiani E, Bertaina I, Pacchetti C (2011) Mild cognitive impairment in Parkinson's disease (abs.). Basal Ganglia 1:174
96. Paulus W, Jellinger K (1991) The neuropathologic basis of different clinical subgroups of Parkinson's disease. J Neuropathol Exp Neurol 50:743-755
97. Peltz CB, Corrada MM, Berlau DJ, Kawas CH (2011) Cognitive impairment in nondemented oldest-old: prevalence and relationship to cardiovascular risk factors. Alzheimers Dement, (in press). http://dx.doi.org/10.1016/j.jalz.2011. 02.008
98. Petersen RC, Morris JC (2005) Mild cognitive impairment as a clinical entity and treatment target. Arch Neurol 62:1160-1163 Discussion 1167 (Pubitemid 41043744)
99. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56:303-308 (Pubitemid 29120227)
100. Petersen RC, Parisi JE, Dickson DW, Johnson KA, Knopman DS, Boeve BF, Jicha GA, Ivnik RJ, Smith GE, Tangalos EG, Braak H, Kokmen E (2006) Neuropathologic features of amnestic mild cognitive impairment. Arch Neurol 63:665-672
101. Petersen RC, Roberts RO, Knopman DS, Boeve BF, Geda YE, Ivnik RJ, Smith GE, Jack CR Jr (2009) Mild cognitive impairment: ten years later. Arch Neurol 66:1447-1455
102. Plassman BL, Langa KM, McCammon RJ, Fisher GG, Potter GG, Burke JR, Steffens DC, Foster NL, Giordani B, Unverzagt FW, Welsh-Bohmer KA, Heeringa SG, Weir DR, Wallace RB (2011) Incidence of dementia and cognitive impairment, not dementia in the United States. Ann Neurol 70:418-426
103. Rabin LA, Borgos MJ, Saykin AJ, Wishart HA, Crane PK, Nutter-Upham KE, Flashman LA (2007) Judgment in older adults: development and psychometric evaluation of the test of practical judgment (TOP-J). J Clin Exp Neuropsychol 29:752-767 (Pubitemid 47481216)
104. Reid WG, Hely MA, Morris JG, Loy C, Halliday GM (2011) Dementia in Parkinson's disease: a 20-year neuropsychological study (sydney multicentre study). J Neurol Neurosurg Psychiatry 82:1033-1037
105. Reisberg B, Ferris SH, de Leon MJ, Franssen ESE, Kluger A, Mir P, Borenstein J, George AE, Shulman E, Steinberg G, Cohen J (1988) Stage-specific behavioral, cognitive, and in vivo changes in community residing subjects with age-associated memory impairment and primary degenerative dementia of the Alzheimer type. Drug Dev Res 15:104-114 (Pubitemid 19151267)
106. Riederer P, Bartl J, Laux G, Grunblatt E (2011) Diabetes type II: a risk factor for depression-Parkinson-Alzheimer? Neurotoxic Res 19:253-265
107. Rinne JO, Nagren K (2010) Positron emission tomography in at risk patients and in the progression of mild cognitive impairment to Alzheimer's disease. J Alzheimers Dis 19:291-300
108. Roberts RO, Geda YE, Knopman DS, Cha RH, Pankratz VS, Boeve BF, Ivnik RJ, Tangalos EG, Petersen RC, Rocca WA (2008) The mayo clinic study of aging: design and sampling, participation, baseline measures and sample characteristics. Neuroepidemiol 30:58-69 (Pubitemid 351311727)
109. Rolstad S, Nordlund A, Eckerstrom C, Gustavsson MH, Zetterberg H, Wallin A (2009) Biomarkers in relation to cognitive reserve in patients with mild cognitive impairment - proof of concept. Dement Geriatr Cogn Disord 27:194-200
110. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A et al (1993) Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN international workshop. Neurology 43:250-260 (Pubitemid 23060253)
111. Sabbagh MN, Shah F, Reid RT, Sue L, Connor DJ, Peterson LK, Beach TG (2006) Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal aging. Arch Neurol 63:1771-1776 (Pubitemid 44925087)
112. Saito Y, Murayama S (2007) Neuropathology of mild cognitive impairment. Neuropathology 27:578-584 (Pubitemid 350045670)
113. Scheff SW, Price DA, Schmitt FA, Mufson EJ (2006) Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment. Neurobiol Aging 27:1372-1384 (Pubitemid 44279897)
114. Scheff SW, Price DA, Schmitt FA, DeKosky ST, Mufson EJ (2007) Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology 68:1501-1508 (Pubitemid 46685921)
115. Scheff SW, Price DA, Schmitt FA, Scheff MA, Mufson EJ (2011) Synaptic loss in the inferior temporal gyrus in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis 24:547-557
116. Schneider JA, Arvanitakis Z, Leurgans SE, Bennett DA (2009) The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol 66:200-208
117. Schuff N, Woerner N, Boreta L, Kornfield T, Shaw LM, Trojanowski JQ, Thompson PM, Jack CR Jr, Weiner MW (2009) MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers. Brain 132:1067-1077
118. Sexton CE, Kalu UG, Filippini N, Mackay CE, Ebmeier KP (2011) A meta-analysis of diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 32(12):2322.e5-e18
119. Shi M, Huber BR, Zhang J (2010) Biomarkers for cognitive impairment in Parkinson disease. Brain Pathol 20:660-671
120. Siderowf A, Xie SX, Hurtig H, Weintraub D, Duda J, Chen-Plotkin A, Shaw LM, Van Deerlin V, Trojanowski JQ, Clark C (2010) CSF amyloid beta 1-42 predicts cognitive decline in Parkinson disease. Neurology 75:1055-1061
121. Silbert LC, Kaye J (2010) Neuroimaging and cognition in Parkinson's disease dementia. Brain Pathol 20:646-653
122. Sollinger AB, Goldstein FC, Lah JJ, Levey AI, Factor SA (2010) Mild cognitive impairment in Parkinson's disease: subtypes and motor characteristics. Parkinsonism Relat Disord 16:177-180
123. Sonnen JA, Montine KS, Quinn JF, Breitner JC, Montine TJ (2010) Cerebrospinal fluid biomarkers in mild cognitive impairment and dementia. J Alzheimers Dis 19:301-309
124. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH (2011) Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7:280-292
125. Stephan BC, Matthews FE, Hunter S, Savva GM, Bond J, McKeith IG, Ince P, Brayne C (2012) Neuropathological profile of mild cognitive impairment from a population perspective. Alzheimer Dis Assoc Disord, (in press). doi: 10.1097/WAD.1090b1013e31822fc31824d
126. Storandt M, Grant EA, Miller JP, Morris JC (2006) Longitudinal course and neuropathologic outcomes in original vs. revised MCI and in pre-MCI. Neurology 67:467-473 (Pubitemid 44214972)
127. Taragano FE, Allegri RF, Krupitzki H, Sarasola DR, Serrano CM, Lon L, Lyketsos CG (2009) Mild behavioral impairment and risk of dementia: a prospective cohort study of 358 patients. J Clin Psychiatry 70:584-592
128. Tröster AI (2008) Neuropsychological characteristics of dementia with Lewy bodies and Parkinson's disease with dementia: differentiation, early detection, and implications for "mild cognitive impairment" and biomarkers. Neuropsychol Rev 18:103-119
129. Tröster AI (2011) A Precis of Recent Advances in the Neuropsychology of Mild Cognitive Impairment(s) in Parkinson's Disease and a Proposal of Preliminary Research Criteria. J Int Neuropsychol Soc 8:1-14
130. Uc EY, McDermott MP, Marder KS, Anderson SW, Litvan I, Como PG, Auinger P, Chou KL, Growdon JC (2009) Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort. Neurology 73:1469-1477
131. Vana L, Kanaan NM, Ugwu IC, Wuu J, Mufson EJ, Binder LI (2011) Progression of tau pathology in cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer's disease. Am J Pathol 179:2533-2550
132. Wallin A, Gothlin M, Gustavsson M, Zetterberg H, Eckerstrom C, Blennow K, Edman A, Lind K, Nordlund A, Rolstad S (2011) Progression from mild to pronounced MCI is not associated with cerebrospinal fluid biomarker deviations. Dement Geriatr Cogn Disord 32:193-197
133. Ward A, Arrighi HM, Michels S, Cedarbaum JM (2012) Mild cognitive impairment: Disparity of incidence and prevalence estimates. Alzheimers Dement 8:14-21
134. Weintraub D, Doshi J, Koka D, Davatzikos C, Siderowf AD, Duda JE, Wolk DA, Moberg PJ, Xie SX, Clark CM (2011) Neurodegeneration across stages of cognitive decline in Parkinson disease. Arch Neurol 68:1562-1568
135. Weintraub D, Dietz N, Duda JE, Wolk DA, Doshi J, Xie SX, Davatzikos C, Clark CM, Siderowf A (2012) Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease. Brain 135:170-180
136. Williams-Gray CH, Foltynie T, Brayne CE, Robbins TW, Barker RA (2007) Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain 130:1787-1798 (Pubitemid 47343805)
137. Williams-Gray CH, Evans JR, Goris A, Foltynie T, Ban M, Robbins TW, Brayne C, Kolachana BS, Weinberger DR, Sawcer SJ, Barker RA (2009a) The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. Brain 132:2958-2969
138. Williams-Gray CH, Goris A, Saiki M, Foltynie T, Compston DA, Sawcer SJ, Barker RA (2009b) Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson's disease. J Neurol 256:493-498
139. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Backman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC (2004) Mild cognitive impairment - beyond controversies, towards a consensus: report of the international working group on mild cognitive impairment. J Intern Med 256:240-246 (Pubitemid 39222993)
140. Wolk DA, Price JC, Saxton JA, Snitz BE, James JA, Lopez OL, Aizenstein HJ, Cohen AD, Weissfeld LA, Mathis CA, Klunk WE, De-Kosky ST (2009) Amyloid imaging in mild cognitive impairment subtypes. Ann Neurol 65:557-568
141. Zgaljardic DJ, Foldi NS, Borod JC (2004) Cognitive and behavioral dysfunction in Parkinson's disease: neurochemical and clinicopathological contributions. J Neural Transm 111:1287-1301 (Pubitemid 39468391)
142. Zhang H, Trollor JN, Wen W, Zhu W, Crawford JD, Kochan NA, Slavin MJ, Brodaty H, Reppermund S, Kang K, Mather KA, Sachdev PS (2011) Grey matter atrophy of basal forebrain and hippocampus in mild cognitive impairment. J Neurol Neurosurg Psychiatry 82:487-493
143. Zihl J, Reppermund S, Thum S, Unger K (2010) Neuropsychological profiles in MCI and in depression: differential cognitive dysfunction patterns or similar final common pathway disorder? J Psychiatr Res 44:647-654